Leap Therapeutics, Inc.
LPTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25,969 | -$16,643 | -$15,435 | -$15,431 |
| Dep. & Amort. | $775 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,156 | $1,489 | $1,204 | $0 |
| Change in WC | $1,749 | $552 | -$363 | -$2,067 |
| Other Non-Cash | $4,997 | $116 | $114 | $1,986 |
| Operating Cash Flow | -$16,292 | -$14,486 | -$14,480 | -$15,512 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,992 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $15,984 | $0 | $0 | $0 |
| Investing Cash Flow | $13,992 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$13 | -$119 | -$77 | $0 |
| Stock Issued | $0 | $0 | $16 | $104 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $226 | $0 | $0 | $0 |
| Financing Cash Flow | $213 | -$119 | -$61 | $104 |
| Forex Effect | $0 | $22 | $5 | -$166 |
| Net Chg. in Cash | -$2,087 | -$14,583 | -$14,536 | -$15,574 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $28,849 | $32,713 | $47,249 | $62,823 |
| End Cash | $26,762 | $18,130 | $32,713 | $47,249 |
| Free Cash Flow | -$18,284 | -$14,486 | -$14,480 | -$15,512 |